Document:

Amended and Restated PharMerica Corp 2007 Omnibus Incentive Plan

 Exhibit 10.9 
 AMENDED AND RESTATED PHARMERICA CORPORATION 
 2007 OMNIBUS INCENTIVE PLAN 
 SECTION 1. Purpose. The purpose of the Amended and Restated PharMerica Corporation 2007 Omnibus Incentive Plan is to enhance the incentive of
those employees, directors and other individuals who are expected to contribute significantly to the success of the Company and its Affiliates to perform at the highest level, and, in general, to further the best interests of the Company and its
stockholders. This plan has been amended and restated, effective as of January 1, 2009. 
 SECTION 2. Definition.

 As used in the Plan, the following terms shall have the meanings set forth below: 
 (a) “ Act ” shall mean the Securities Exchange Act of 1934, as amended. 
 (b) “ Affiliate ” shall mean (i) any entity that, directly or indirectly, controls, is controlled by or under common
control with the Company and (ii) any entity in which the Company has a significant equity interest, in either case as determined by the Committee. 
 (c) “ Award ” shall mean any Option, Stock Appreciation Right, award of Restricted Stock, Restricted Stock Unit, Deferred Stock, Performance Award or Other Stock-Based Award granted under the Plan,
which may be denominated or settled in Shares, cash or in such other forms as provided for herein. 
 (d) “ Award
Agreement ” shall mean any written agreement, contract or other instrument or document evidencing any Award granted under the Plan, which may, but need not, be executed or acknowledged by a Participant. 
 (e) “ Beneficiary ” shall mean a person or persons entitled to receive payments or other benefits or exercise rights that
are available under the Plan in the event of the Participant’s death. If no such person is named by a Participant who is an individual, such individual’s Beneficiary shall be the individual’s estate. 
 (f) “ Board ” shall mean the board of directors of the Company. 
 (g) “ Change in Control ” shall mean the occurrence of: 
 (i) any “person” (as defined in Section 13(d) of the Act other than the Company, its Affiliates or an employee benefit plan
or trust maintained by the Company or its affiliates, becoming the “beneficial owner” (as defined in Rule 13d-3 under the Act), directly or indirectly, of 40% or more of the combined voting power of the Company’s then outstanding
Voting Stock (excluding any “person” who becomes such a beneficial owner in connection with a transaction described in clause (A) of paragraph (iii) below); 
 (ii) at any time during a period of twelve consecutive months, individuals who at the beginning of such period constituted the Board (and
any new member of the Board whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the members of the Board then still in office who either were members of the Board
at the beginning of the period or whose election or nomination was so approved) cease for any reason to constitute at least a majority of members then constituting the Board; or 
 (iii) the consummation of (A) a merger or consolidation of the Company or any direct or indirect subsidiary of the Company with any
other corporation, other than a merger or consolidation which would result in the Voting Stock of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or being converted
into Voting Stock of the surviving entity or any parent thereof) at least 50% of the combined voting power of the Voting Stock, or the total fair market value of all the securities, of the Company or such surviving entity or any parent thereof
outstanding immediately after such merger or consolidation, or (B) any sale, lease, 

  

 1 

 
exchange or other transfer (in one transaction or a series of transactions) of assets of the Company having a total gross fair market value equal to more
than 40% of the total gross Fair Market Value of all assets of the Company immediately prior to such transaction or transactions. 
 Notwithstanding the foregoing, (i) in no event shall a Change in Control be deemed to have occurred with respect to a Participant if the Participant is part of a “group”, within the meaning of Section 13(d)(3) of the
Act, which consummates the Change in Control transaction and (ii) an Award Agreement may provide for a definition of the term “Change in Control” with respect to an Award that is different from the definition provided above.

 (h) “ Code ” shall mean the Internal Revenue Code of 1986, as amended from time to time. 
 (i) “ Committee ” shall mean the Compensation Committee of the Board or such other committee as may be designated by the
Board that satisfies the requirements of applicable law. If the Board does not designate the Committee, references herein to the “Committee” shall refer to the Board. 
 (j) “ Company ” shall mean PharMerica Corporation, a Delaware corporation. 
 (k) “ Covered Employee ” means an individual who is a “covered employee” within the meaning of
Section 162(m)(3) of the Code, or any successor provision. 
 (l) “ Deferred Stock ” shall mean a right
to receive Shares or other Awards or a combination thereof at the end of a specified deferral period, granted under Section 9. 
 (m) “ Fair Market Value ” shall mean with respect to Shares, the closing price of a Share on the date in question (or, if there is no reported sale on such date, on the last preceding date on which any reported sale
occurred) on the principal stock exchange on which the Shares trade or are quoted, or if Shares are not so listed or quoted, fair market value as determined by the Committee, and with respect to any property other than Shares, the fair market value
of such property determined by such methods or procedures as shall be established from time to time by the Committee. 
 (n)
“ Incentive Stock Option ” shall mean an option representing the right to purchase Shares from the Company, granted under and in accordance with the terms of Section 6, that (i) meets the requirements of Section 422
of the Code, or any successor provision thereto and (ii) is designated by the Committee in the applicable Award Agreement as an Incentive Stock Option. 
 (o) “ Non-Qualified Stock Option ” shall mean an option representing the right to purchase Shares from the Company,
granted under and in accordance with the terms of Section 6, that is not an Incentive Stock Option. 
 (p) “
Option ” shall mean an Incentive Stock Option or a Non-Qualified Stock Option. 
 (q) “ Other Stock-Based
Award ” means an Award granted pursuant to Section 11 of the Plan. 
 (r) “ Participant ” shall
mean the recipient of an Award granted under the Plan. 
 (s) “ Performance Award ” means an Award granted
pursuant to Section 10 of the Plan, including, but not limited to, one intended to be “qualified performance-based compensation” under Section 162(m) of the Code. 
 (t) “ Performance Period ” means the period established by the Committee at the time any Performance Award is granted or
at any time thereafter during which any performance goals specified by the Committee with respect to such Award are measured and must be met. 
 (u) “ Plan ” shall mean the Amended and Restated PharMerica Corporation 2007 Omnibus Incentive Plan as the same may be amended from time to time. 
 (v) “ Restricted Stock ” shall mean any Share granted under Section 8. 
 (w) “ Restricted Stock Unit ” shall mean a contractual right granted under Section 8 that is denominated in Shares.
Each Unit represents a right to receive the value of one Share (or a percentage of such value) upon the terms and conditions set forth in the Plan and the applicable Award Agreement. Awards of Restricted Stock Units may include, without limitation,
the right to receive dividend equivalents. 
  

 2 

 (x) “ SAR ” or “ Stock Appreciation Right ” shall mean
any right granted to a Participant pursuant to Section 7 to receive, upon exercise by the Participant, the excess of (i) the Fair Market Value of one Share on the date of exercise over (ii) the grant price of the right specified by
the Committee in its sole discretion, which, except in the case of Substitute Awards or in connection with an adjustment provided in Section 5(d), shall not be less than the Fair Market Value of one Share on such date of grant of the right.

 (y) “ Service ” shall mean the active performance of services for the Company or an Affiliate by a person
who is an employee or director of the Company or an Affiliate. 
 (z) “ Shares ” shall mean shares of the
common stock of the Company. 
 (aa) “ Subsidiary ” shall mean a subsidiary of the Company within the meaning
of Section 424(f) of the Code. 
 (bb) “ Substitute Awards ” shall mean Awards granted in assumption of,
or in substitution for, outstanding awards previously granted by a company acquired by the Company or with which the Company combines; provided that the terms and conditions of each such Substitute Award (including, without limitation, the exercise
price and number of Shares subject to such Substitute Award) shall be determined in accordance with U.S. Department of Treasury Regulation §1.409A-1(b)(5)(v)(D). 
 (cc) “ Voting Stock ” shall mean securities entitled to vote generally on the election of the Board. 
 SECTION 3. Eligibility. 
 (a) Any employee, member of the Board, consultant or other advisor of, or any other individual who provides services to, the Company or any Affiliate, shall be eligible to be selected to receive an Award under the Plan, except that
Incentive Stock Options may be granted only to employees of the Company or a Subsidiary. 
 (b) Holders of options and other
types of awards granted by a company acquired by the Company or with which the Company combines are eligible for grant of Substitute Awards hereunder. 
 SECTION 4. Administration. 
 (a) The Plan shall be administered by the Committee.
The Committee shall consist of not less than three directors. Each Committee member shall be (i) independent, within the meaning of and to the extent required by applicable rulings and interpretations of the Securities and Exchange Commission
and the applicable stock exchange on which the Shares trade or are quoted and (ii) an outside director pursuant to Section 162(m) of the Code, and any regulations issued thereunder, in each case at such time as the Company becomes subject
to the respective regulatory regime. The Board may designate one or more directors as alternate members of the Committee who may replace any absent or disqualified member at any meeting of the Committee. The Committee may delegate to one or more of
the Committee’s members or to officers of the Company the authority to exercise all duties and responsibilities of the Committee under the Plan, including those listed in Section 4(b) below or such of those duties and responsibilities as
may be specified by the Committee, except that such delegation shall not be applicable to any Award for a person then covered by Section 16 of the Act. The Committee may issue rules and regulations for administration of the Plan. It shall meet
at such times and places as it may determine. 
 (b) Subject to the terms of the Plan and applicable law, the Committee (or
its delegate) shall have full power and authority to: (i) designate Participants; (ii) determine the type or types of Awards (including Substitute Awards) to be granted to each Participant under the Plan; (iii) determine the number of
Shares to be covered by (or with respect to which payments, rights, or other matters are to be calculated in connection with) Awards; (iv) determine the terms and conditions of any Award; (v) adopt form of Award Agreements;
(vi) determine whether, to what extent, and under what circumstances Awards may be settled or exercised in cash, Shares, other securities, or other Awards, or canceled, forfeited or suspended, and the method or methods by which Awards may be
settled, exercised, canceled, forfeited or suspended; (vii) correct any defect, supply any omission or reconcile any inconsistency in or among the Plan, an Award or an Award Agreement; (viii) determine whether, to what extent, 

  

 3 

 
and under what circumstances cash, Shares, other securities, other Awards, and other amounts payable with respect to an Award under the Plan shall be
deferred either automatically or at the election of the holder thereof or of the Committee; (ix) interpret and administer the Plan and any instrument or agreement relating to, or Award made under, the Plan; (x) establish, amend, suspend or
waive such rules and regulations and appoint such agents as it shall deem appropriate for the proper administration of the Plan; and (xi) make any other determination and take any other action that the Committee deems necessary or desirable for
the administration of the Plan. 
 (c) All decisions of the Committee shall be final, conclusive and binding upon all parties,
including the Company, the stockholders and the Participants. 
 SECTION 5. Shares Available for Awards. 
 (a) Subject to adjustment as provided in Section 5(d) below, the maximum number of Shares available for delivery under the Plan is
3,800,000 Shares. Notwithstanding the foregoing and subject to adjustment as provided in Section 5(d), the maximum number of Shares that may be subject to grant of Incentive Stock Options is 3,800,000, the maximum number of Shares that are
available for Awards under Sections 8, 9 and 11 is 1,900,000 and no Participant may receive Options and SARs under the Plan in any fiscal year that relate to more than 650,000 Shares. 
 (b) If, after the effective date of the Plan, any Shares covered by an Award other than a Substitute Award, or to which such an Award
relates, are forfeited, or if such an Award otherwise terminates without the delivery of Shares or of other consideration, then the Shares covered by such Award, or to which such Award relates, to the extent of any such forfeiture or termination,
shall again be, or shall become, available for issuance under the Plan. 
 (c) Any Shares delivered pursuant to an Award may
consist, in whole or in part, of authorized and unissued Shares or Shares acquired by the Company. 
 (d) In the event that
the Committee shall determine that any dividend or other distribution (whether in the form of cash, Shares or other securities), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off,
combination, repurchase or exchange of Shares or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company, or other similar corporate transaction or event affects the Shares such
that an adjustment is determined by the Committee to be appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, then the Committee shall, in such manner as it may
deem equitable, adjust any or all of (i) the number and type of Shares (or other securities) which thereafter may be made the subject of Awards, including the aggregate and individual limits specified in Section 5(a) and
Section 10(c), (ii) the number and type of Shares (or other securities) subject to outstanding Awards, and (iii) the grant, purchase, or exercise price with respect to any Award or, if deemed appropriate, make provision for a cash
payment to the holder of an outstanding Award; provided, however, that the number of Shares subject to any Award denominated in Shares shall always be a whole number. 
 (e) Shares underlying Substitute Awards shall not reduce the number of Shares remaining available for issuance under the Plan. 

SECTION 6. Options. 
 (a) The Committee is hereby authorized to grant Options to Participants with the terms and conditions set forth in this Section 6 and with such additional terms and conditions as set forth in an Award Agreement, in either case not
inconsistent with the provisions of the Plan, as the Committee shall determine: 
 (b) The purchase price per Share under an
Option shall be determined by the Committee; provided, however, that, except in the case of Substitute Awards, such purchase price shall not be less than the Fair Market Value of a Share on the date of grant of such Option. 

 

 4 

 (c) The term of each Option shall be fixed by the Committee but shall not exceed 10 years
from the date of grant thereof. 
 (d) The Committee shall determine the time or times at which an Option may be exercised in
whole or in part. 
 (e) The Committee shall determine the method or methods by which, and the form or forms, including,
without limitation, cash, Shares, other Awards, or any combination thereof, having a Fair Market Value on the exercise date equal to the relevant exercise price, in which, payment of the exercise price with respect thereto may be made or deemed to
have been made. 
 (f) The terms of any Incentive Stock Option granted under the Plan shall comply in all respects with the
provisions of Section 422 of the Code, or any successor provision thereto, and any regulations promulgated thereunder. 
 (g) Each Option shall be evidenced by an Award Agreement which contains the terms and conditions of the Option as determined by the Committee. 
 SECTION 7. Stock Appreciation Rights. 
 (a) The Committee is hereby authorized to
grant Stock Appreciation Rights (“ SARs ”) to Participants with terms and conditions as the Committee shall determine not inconsistent with the provisions of the Plan. Each SAR shall be evidenced by an Award Agreement which includes
the terms and conditions determined by the Committee. 
 (b) SARs may be granted hereunder to Participants either alone
(“ freestanding ”) or in addition to other Awards granted under the Plan (“ tandem ”) and may, but need not, relate to a specific Option granted under Section 6. 
 (c) Any tandem SAR related to an Option may be granted at the same time such Option is granted or at any time thereafter before exercise
or expiration of such Option. In the case of any tandem SAR related to any Option, the SAR or applicable portion thereof shall not be exercisable until the related Option or applicable portion thereof is exercisable and shall terminate and no longer
be exercisable upon the termination or exercise of the related Option, except that a SAR granted with respect to less than the full number of Shares covered by a related Option shall not be reduced until the exercise or termination of the related
Option exceeds the number of Shares not covered by the SAR. Any Option related to any tandem SAR shall no longer be exercisable to the extent the related SAR has been exercised. 
 (d) A freestanding SAR shall not have a term of greater than 10 years or, unless it is a Substitute Award, an exercise price less than the
Fair Market Value of the Share on the date of grant. 
 SECTION 8. Restricted Stock and Restricted Stock Units. 
 (a) The Committee is hereby authorized to grant Awards of Restricted Stock and Restricted Stock Units to Participants. Each Award of
Restricted Stock and Restricted Stock Units shall be evidenced by an Award Agreement which shall set forth the conditions, if any, which will need to be satisfied before the grant will be effective and the conditions, if any, under which the
Participant’s interest in the related Shares or the value of the Restricted Stock Units will be forfeited or become vested, including performance goals, if any, that must be achieved as a condition to vesting of the Restricted Stock Award or
the Restricted Stock Unit. The Committee, in its discretion, may award dividend equivalents with respect to Awards of Restricted Stock and Restricted Stock Units. 
 (b) Shares of Restricted Stock and Restricted Stock Units shall be subject to such restrictions as the Committee may impose (including,
without limitation, any limitation on the right to vote a Share of Restricted Stock or the right to receive any dividend or other right), which restrictions may lapse separately or in combination at such time or times, in such installments or
otherwise, as the Committee may deem appropriate. 
  

 5 

 (c) Any share of Restricted Stock granted under the Plan may be evidenced in such manner
as the Committee may deem appropriate including, without limitation, book-entry registration or issuance of a stock certificate or certificates. In the event any stock certificate is issued in respect of shares of Restricted Stock granted under the
Plan, such certificate shall be registered in the name of the Participant and shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted Stock. 
 (d) The Committee may in its discretion, when it finds that a waiver would be in the best interests of the Company, waive in whole or in
part any or all restrictions with respect to Shares of Restricted Stock or Restricted Stock Units. 
 (e) If the Committee
intends that an Award under this Section 8 shall constitute or give rise to “qualified performance based compensation” under Section 162(m) of the Code, such Award may be structured in accordance with the requirements of
Section 10(c), including without limitation, the performance criteria and the Award limitation set forth therein, and any such Award shall be considered a Performance Award for purposes of the Plan. 
 SECTION 9. Deferred Stock. The Committee is authorized to grant Deferred Stock to Participants, subject to terms and conditions set forth in
this Section 9 and with such additional terms and conditions, in either case not inconsistent with the provisions of the Plan, as the Committee shall determine. Each grant of Deferred Stock shall be evidenced by an Award Agreement which
contains the terms and conditions determined by the Committee. 
 (a) Issuance of Shares will occur upon expiration of the
deferral period specified for an Award of Deferred Stock by the Committee (or, if permitted by the Committee, as elected by the Participant). In addition, Deferred Stock shall be subject to such restrictions on transferability, risk of forfeiture
and other restrictions, if any, as the Committee may impose, which restrictions may lapse at the expiration of the deferral period or at earlier specified times (including based on achievement of performance goals and/or future service
requirements), separately or in combination, in installments or otherwise, and under such other circumstances as the Committee may determine at the date of grant or thereafter. Deferred Stock may be satisfied by delivery of Shares, other Awards, or
a combination thereof, as determined by the Committee at the date of grant or thereafter. 
 (b) The Committee, in its
discretion, may award dividend equivalents with respect to Awards of Deferred Stock. 
 SECTION 10. Performance Awards.

 (a) The Committee is hereby authorized to grant Performance Awards to Participants with terms and conditions as the
Committee shall determine not inconsistent with the provisions of the Plan. Each grant of Performance Awards shall be evidenced by an Award Agreement which contains the terms and conditions determined by the Committee. The Committee, in its
discretion, may award dividend equivalents with respect to Performance Awards. 
 (b) Performance Awards may be denominated as
a cash amount, number of Shares, or a combination thereof and are Awards which may be earned upon achievement or satisfaction of performance conditions specified by the Committee. In addition, the Committee may specify that any other Award shall
constitute a Performance Award by conditioning the right of a Participant to exercise the Award or have it settled, and the timing thereof, upon achievement or satisfaction of such performance conditions as may be specified by the Committee. The
Committee may use such business criteria and other measures of performance as it may deem appropriate in establishing any performance conditions. Subject to the terms of the Plan, the performance goals to be achieved during any Performance Period,
the length of any Performance Period, the amount of any Performance Award granted and the amount of any payment or transfer to be made pursuant to any Performance Award shall be determined by the Committee and set forth in the Award Agreement.

  

 6 

 (c) Every Performance Award shall, if the Committee intends that such Award should
constitute “qualified performance-based compensation” for purposes of Section 162(m) of the Code, include a pre-established formula, such that payment, retention or vesting of the Award is subject to the achievement during a
performance period or periods, as determined by the Committee, of a level or levels of, or increases in, in each case as determined by the Committee, one or more performance measures with respect to the Company, any Subsidiary and/or any business
unit of the Company or any Subsidiary, including without limitation the following: return on equity or average equity, diluted earnings per share, total earnings, earnings growth, return on capital or average capital, return on assets or net assets,
earnings before interest and taxes, EBITDA, EBITDA minus capital expenditures, sales or sales growth, customer or customer growth, traffic, revenue or revenue growth, income or net income, net income before share-based payments, gross margin return
on investment, increase in the fair market value of common stock, share price (including, but not limited to, growth measures and total stockholder return), operating profit, gross profit, net earnings, cash flow (including, but not limited to,
operating cash flow and free cash flow), cash flow return on investment (which equals net cash flow divided by total capital), capital expenditures, operating expenses, selling, general and administrative expenses, operating income or net operating
income, return on investment, inventory turns, return on sales, financial return ratios, total return to stockholders, market share, earnings measures/ratios, economic value added (EVA), balance sheet measurements such as receivable turnover,
internal rate of return, increase in net present value, or expense targets, customer satisfaction surveys and productivity. The Committee may also exclude charges related to an event or occurrence which the Committee determines should appropriately
be excluded, including (a) restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring charges, (b) an event either not directly related to the operations of the Company or not within the reasonable
control of the Company’s management, or (c) the cumulative effects of tax or accounting changes in accordance with U.S. generally accepted accounting principles. Performance criteria may be measured on an absolute (e.g., plan or budget) or
relative basis. Relative performance may be measured against a group of peer companies, a financial market index, or other acceptable objective and quantifiable indices. Except in the case of an award intended to qualify as “performance-based
compensation” under Section 162(m) of the Code, if the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company, or the manner in which the Company conducts its business, or
other events or circumstances render the performance objectives unsuitable, the Committee may modify the performance objectives or the related minimum acceptable level of achievement, in whole or in part, as the Committee deems appropriate and
equitable. Performance measures may vary from Performance Award to Performance Award, respectively, and from Participant to Participant, and may be established on a stand-alone basis, in tandem or in the alternative. For any Award subject to any the
pre-established formula described herein, the maximum number of shares subject to any such Award denominated in Shares granted in any fiscal year to a Participant shall be 500,000 Shares, subject to adjustment as provided in Section 5(d), and
the maximum amount earned in respect of a Performance Award denominated in cash or value other than Shares on an annualized fiscal year basis with respect to any Participant shall be $5,000,000. The Committee shall have the power to impose such
other restrictions on Awards subject to this Section 10(c) as it may deem necessary or appropriate to ensure that such Awards satisfy all requirements for “performance-based compensation” within the meaning of
Section 162(m)(4)(C) of the Code, or any successor provision thereto. Notwithstanding any provision of the Plan to the contrary, the Committee shall not be authorized to increase the amount payable under any Award to which this
Section 10(c) applies upon attainment of such pre-established formula. 
 (d) Settlement of Performance Awards shall be
in cash, Shares, other Awards or other property, or a combination thereof, in the discretion of the Committee as set forth in the applicable Award Agreement. Performance Awards will be distributed only after the end of the relevant Performance
Period. The Committee may, in its discretion, increase or reduce the amount of a settlement otherwise to be made in connection with such Performance Awards, but may not exercise discretion to increase any such amount payable to a Covered Employee in
respect of a Performance Award subject to paragraph (c) above. Any settlement which changes the form of payment from that originally specified shall be implemented in a manner such that the Performance 

  

 7 

 
Award and other related Awards do not, solely for that reason, fail to qualify as “performance-based compensation” for purposes of
Section 162(m) of the Code. The Committee shall specify the circumstances in which such Performance Awards shall be paid or forfeited in the event of termination of employment by the Participant. 
 SECTION 11. Other Stock-Based Awards. The Committee is authorized, subject to limitations under applicable law, to grant to Participants such
other Awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Shares or factors that may influence the value of Shares, including, without limitation, convertible or
exchangeable debt securities, other rights convertible or exchangeable into Shares, purchase rights for Shares, Awards with value and payment contingent upon performance of the Company or business units thereof or any other factors designated by the
Committee. The Committee shall determine the terms and conditions of such Awards and such terms and conditions shall be contained in an Award Agreement which evidences such Award. Shares delivered pursuant to an Award in the nature of a purchase
right granted under this Section 11 shall be purchased for such consideration, paid for at such times, by such methods, and in such forms, including, without limitation, cash, Shares, other Awards, notes, or other property, as the Committee
shall determine. Cash awards, as an element of or supplement to any other Award under the Plan, may also be granted pursuant to this Section 11. The Committee, in its discretion, may award dividend equivalents with respect to Awards granted
pursuant to this Section 11. 
 SECTION 12. Effect of Termination of Service on Awards. The Committee may provide, by rule
or regulation or in any Award Agreement, or may determine in any individual case, the circumstances in which Awards shall be exercised, vested, paid or forfeited in the event a Participant ceases to provide Service to the Company or any Affiliate
prior to the end of a performance period or exercise or settlement of such Award; provided that, to the extent such Award is subject to Section 409A of the Code, the Committee’s determination provided for in this Section 12 shall
comply with Section 409A of the Code and the regulations promulgated thereunder. 
 SECTION 13. General Provisions Applicable to
Awards. 
 (a) Awards shall be granted for no cash consideration or for such minimal cash consideration as may be required
by applicable law. 
 (b) Awards may, in the discretion of the Committee, be granted either alone or in addition to or in
tandem with any other Award or any award granted under any other plan of the Company. Awards granted in addition to or in tandem with other Awards, or in addition to or in tandem with awards granted under any other plan of the Company, may be
granted either at the same time as or at a different time from the grant of such other Awards or awards. 
 (c) Subject to the
terms of the Plan, payments or transfers to be made by the Company upon the grant, exercise or payment of an Award may be made in the form of cash, Shares, other securities or other Awards, or any combination thereof, as determined by the Committee
in its discretion at the time of grant, and may be made in a single payment or transfer, in installments, or on a deferred basis, in each case in accordance with rules and procedures established by the Committee. Such rules and procedures may
include, without limitation, provisions for the payment or crediting of reasonable interest on installment or deferred payments or the grant or crediting of dividend equivalents in respect of installment or deferred payments. 
 (d) Except as may be permitted by the Committee or as specifically provided in an Award Agreement, (i) no Award and no right under
any Award shall be encumbered, assignable, alienable, saleable or transferable by a Participant otherwise than by will or pursuant to Section 13(e) and (ii) each Award, and each right under any Award, shall be exercisable during the
Participant’s lifetime only by the Participant or, if permissible under applicable law, by the Participant’s guardian or legal representative. The provisions of this paragraph shall not apply to any Award which has been fully exercised,
earned or paid, as the case may be, and shall not preclude forfeiture of an Award in accordance with the terms thereof. 
  

 8 

 (e) A Participant may designate a Beneficiary or change a previous beneficiary
designation at such times prescribed by the Committee by using forms and following procedures approved or accepted by the Committee for that purpose. If no Beneficiary designated by the Participant is eligible to receive payments or other benefits
or exercise rights that are available under the Plan at the Participant’s death, the Beneficiary shall be the Participant’s estate. 
 (f) All certificates for Shares and/or Shares or other securities delivered under the Plan pursuant to any Award or the exercise thereof shall be subject to such stop transfer orders and other restrictions as the
Committee may deem advisable under the Plan or the rules, regulations, and other requirements of the Securities and Exchange Commission, any stock exchange upon which such Shares or other securities are then listed, and any applicable Federal or
state securities laws, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. 
 (g) The applicable Award Agreement shall provide whether, upon a Change in Control, outstanding Options shall become fully exercisable
and/or vested and outstanding Awards (other than Options) shall become fully vested and/or payable. To the extent not provided in the applicable Award Agreement, the Committee shall determine the treatment of outstanding Awards in connection with
any transaction or transactions resulting in a Change in Control after giving due consideration to the federal income tax consequences, if any, under Section 409A of the Code arising from such treatment. 
 (h) The Committee may impose restrictions on any Award with respect to non-competition, confidentiality and other restrictive covenants,
as it deems necessary in its sole discretion. 
 SECTION 14. Amendments and Termination. 
 (a) Except to the extent prohibited by applicable law and unless otherwise expressly provided in an Award Agreement or in the Plan, the
Board may amend, alter, suspend, discontinue, or terminate the Plan or any portion thereof at any time; provided, however, that no such amendment, alteration, suspension, discontinuation or termination shall be made without
(i) stockholder approval if such approval is required by the listed company rules of the stock exchange, if any, on which the Shares are principally traded or quoted or required to comply with Rule 16b-3 of the Act and Section 162(m) or
422 of the Code, or (ii) the consent of the affected Participant, if such action would adversely affect the rights of such Participant under any outstanding Award, except to the extent any such amendment, alteration, suspension, discontinuance
or termination is made to cause the Plan to comply with applicable law, stock exchange rules and regulations or accounting or tax rules and regulations. Notwithstanding anything to the contrary herein, the Committee may amend the Plan in such manner
as may be necessary to enable the Plan to achieve its stated purposes in any jurisdiction in a tax-efficient manner and in compliance with local rules and regulations. 
 (b) The Committee may waive any conditions or rights under, amend any terms of, or amend, alter, suspend, discontinue or terminate, any
Award theretofore granted, prospectively or retroactively, without the consent of any relevant Participant or holder or beneficiary of an Award, provided, however, that no such action shall adversely affect the rights of any affected
Participant or holder or beneficiary under any Award theretofore granted under the Plan, except to the extent any such action is made to cause the Plan to comply with applicable law, stock exchange rules and regulations or accounting or tax rules
and regulations; and provided further that, except as provided in Section 5(d), no such action shall directly or indirectly, through cancellation and regrant or any other method, reduce, or have the effect of reducing, the exercise price
of any Award established at the time of grant thereof and provided further, that the Committee’s authority under this Section 14(b) is limited in the case of Awards subject to Section 10(c), as set forth in Section 10(c).

 (c) Except as noted in Section 10(c), the Committee shall be authorized to make adjustments in the terms and
conditions of, and the criteria included in, Awards in recognition of events (including, without limitation, the events described in Section 5(d)) affecting the Company, or the financial statements of the Company, or of changes in applicable
laws, regulations or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan.

  

 9 

 (d) Any provision of the Plan or any Award Agreement to the contrary notwithstanding, the
Committee may cause any Award granted hereunder to be canceled in consideration of a cash payment or alternative Award made to the holder of such canceled Award equal in value to the Fair Market Value of such canceled Award, except that (i) the
Committee shall give due consideration to the federal income tax consequences arising under Section 409A of the Code prior to taking any such action and (ii) this Section 14(d) shall not be interpreted to permit any transaction that
is prohibited by the second proviso of Section 14(b) relating to the direct or indirect repricing of Awards. 
 (e) The
Committee may correct any defect, supply any omission, or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem desirable to carry the Plan into effect. 
 SECTION 15. Miscellaneous. 
 (a) No employee, Participant or other person shall have any claim to be granted any Award under the Plan, and there is no obligation for uniformity of treatment of employees, Participants, or holders or beneficiaries
of Awards under the Plan. The terms and conditions of Awards need not be the same with respect to each recipient. Any Award granted under the Plan shall be a one-time Award which does not constitute a promise of future grants. The Company, in its
sole discretion, maintains the right to make available future grants hereunder. 
 (b) A Participant granted an Award shall
have no rights as a stockholder of the Company with respect to such Award unless and until such time as certificates of book-entry shares for the Shares underlying the Award are registered in such Participant’s name in the Company’s stock
records. The right of any Participant to receive payment with respect to an Award by virtue of participation in the Plan shall be no greater than the right of any of the Company’s unsecured general creditors. 
 (c) The Company shall be authorized to withhold from any Award granted or any payment due or transfer made under any Award or under the
Plan or from any compensation or other amount owing to a Participant the amount (in cash, Shares, other securities or other Awards) of any federal, state and local withholding taxes due in respect of an Award, its exercise, or any payment or
transfer under such Award or under the Plan and to take such other action (including, without limitation, providing for elective payment of such amounts in cash or Shares by the Participant) as may be necessary in the opinion of the Company to
satisfy all obligations for the payment of such taxes. 
 (d) Nothing contained in the Plan shall prevent the Company from
adopting or continuing in effect other or additional compensation arrangements, and such arrangements may be either generally applicable or applicable only in specific cases. 
 (e) The Plan and all determinations made and actions taken thereunder shall be governed by the internal substantive laws of the State of
Delaware and construed accordingly, to the extent not superseded by applicable federal law. The grant of an Award shall not be construed as giving a Participant the right to be retained in the employ of, or to continue to provide services to, the
Company or any Affiliate. Further, the Company or the applicable Affiliate may at any time dismiss a Participant, free from any liability, or any claim under the Plan, unless otherwise expressly provided in the Plan or in any Award Agreement or in
any other agreement binding the parties. The receipt of any Award under the Plan is not intended to confer any rights on the receiving Participant except as set forth in such Award. 
 (f) If any provision of the Plan or any Award is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction, or
as to any person or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed
amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, person or Award, and the remainder of the Plan and any such Award shall remain
in full force and effect. 
 (g) Neither the Plan nor any Award shall create or be construed to create a trust or separate
fund of any kind or a fiduciary relationship between the Company and a Participant or any other person. To the extent that any person acquires a right to receive payments from the Company pursuant to an Award, such right shall be no greater than the
right of any unsecured general creditor of the Company. 
  

 10 

 (h) No fractional Shares shall be issued or delivered pursuant to the Plan or any Award,
and the Committee shall determine whether cash or other securities shall be paid or transferred in lieu of any fractional Shares, or whether such fractional Shares or any rights thereto shall be canceled, terminated or otherwise eliminated.

 SECTION 16. Effective Date of the Plan. The Plan shall be effective as of July 12, 2007. 
 SECTION 17. Term of the Plan. No Award shall be granted under the Plan after the tenth year anniversary of its adoption by the Board.
However, unless otherwise expressly provided in the Plan or in an applicable Award Agreement, any Award theretofore granted may extend beyond such date, and the authority of the Committee to amend, alter, adjust, suspend, discontinue, or terminate
any such Award, or to waive any conditions or rights under any such Award, and the authority of the Board to amend the Plan, shall extend beyond such date. 
 Section 18. Section 409A of the Code. With respect to Awards subject to Section 409A of the Code, the Plan is intended to comply with the requirements of Section 409A, and the provisions
hereof shall be interpreted in a manner that satisfies the requirements of Section 409A and the related regulations, and the Plan shall be operated accordingly. If any provision of the Plan or any term or condition of any Award would otherwise
frustrate or conflict with this intent, the provision, term or condition will be interpreted and deemed amended so as to avoid this conflict. 
  

 11Employment Agreement between William Monast and PharMerica Corp

 Exhibit 10.52 
 EMPLOYMENT AGREEMENT 
 THIS AGREEMENT by and between PharMerica Corporation and (hereinafter the
“Company”), and William Monast (the “Executive”) is effective as of April 20, 2009 (“Start Date”); 
 WHEREAS, the Board of Directors of the Company (the “Board”), upon the recommendation of the Compensation and Succession Planning Committee of the Board (the “Committee”), has determined that it is in the best interests
of the Company and its shareholders to employ the Executive, effective as of the Start Date, in the position of Executive Vice President Operations, and the Executive desires to serve in that capacity; 
 NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS: 
 1. Employment Period. The Company shall employ the Executive, either directly or through a Subsidiary, and the Executive shall serve the Company or any such Subsidiary, on the terms and conditions set forth in this Agreement, beginning on
the Starting Date and until that employment ceases as provided below in Section 4 (the “Employment Period”). 
 2. Position
and Duties. 
 (a) During the Employment Period, the Executive shall be employed as the Executive Vice President Operations in Louisville,
Kentucky, subject to such changes in title as may be proposed by the Board or the Chief Executive Officer and consented to by the Executive. The Executive shall report to the Chief Executive Officer of the Company and shall perform such duties for
the Company as are related typically to the office of Executive Vice President Operations, in the manner reasonably directed by the Chief Executive Officer of the Company, in his discretion. 
 (b) During the Employment Period, but excluding any periods of vacation and absence due to intermittent illness to which the Executive is entitled, and
any services on corporate, civic or charitable boards or committees, lectures, speaking engagements or teaching engagements that are approved by the Executive’s direct supervisor and that do not significantly interfere with the performance of
the Executive’s responsibilities to the Company or violating the provisions of Section 9, the Executive shall devote his full time and attention during normal business hours to the business and affairs of the Company and the Executive
shall use reasonable efforts to carry out all duties and responsibilities assigned to him faithfully and efficiently. 
 3. Compensation.

 (a) Base Salary. During the Employment Period, the Executive shall receive an annual base salary of $ 350,000, payable bi-weekly in
accordance with the regular payroll practices of the Company. The Executive’s base salary shall be reviewed annually by the Committee and/or the Chief Executive Officer of the Company, in accordance with the Company’s standard practices
for executives generally, and may be increased, but not decreased, as determined by the Committee, in its sole discretion, or by any person or persons to whom the Committee has delegated such authority. 
 (b) Sign-On Bonus: The Executive shall receive a Sign-On Bonus of $80,000, payable as of the Start Date. 
 (c) Annual Bonus and Incentive Plans; Other Benefits. During the Employment Period: (i) the Executive shall be entitled to participate in any
short-term and long-term incentive programs established and/or maintained by the Company for its senior level executives generally; (ii) the Executive shall be entitled to participate in all incentive, savings and retirement plans, practices,
policies 

 
and programs of the Company to at least the same extent as other senior executives of the Company; (iii) the Executive and/or the Executive’s
family, as the case may be, shall be eligible for participation in, and shall receive all benefits under, all welfare benefit plans, practices, policies and programs provided by the Company to at least the same extent as other senior executives of
the Company; and (iv) the Executive shall be entitled to, and the Company shall provide the Executive with 4 weeks of paid time off (PTO) during each calendar year pursuant to the Company’s PTO policy. Executive’s initial Short Term
Incentive Target is 75%. Executive’s initial Long Term Incentive Target is 160%. 
 (d) Expenses. During the Employment Period, the
Executive shall be entitled to receive advancement or prompt reimbursement for all reasonable expenses incurred or anticipated to be incurred by the Executive in carrying out the Executive’s duties under this Agreement, provided that the
Executive complies with the generally applicable policies, practices and procedures of the Company for submission of expense reports, receipts, or similar documentation of such expenses. 
 (e) Relocation Expenses. Executive may receive up to $150,000 in relocation expenses pursuant to the Company relocation policy. Relocation expenses must
be incurred within six (6) months of the Start Date. If Executive voluntarily terminates employment with the Company within one year of Executive’s relocation, then the Executive will reimburse the Company for 100% of the relocation
expenses the Executive received from the Company. The company will provide the Executive with temporary housing for 90 days. 
 4.
Termination of Employment. 
 (a) Death or Disability. The Executive’s employment and the Employment Period shall terminate automatically
upon the Executive’s death or long term Disability during the Employment Period. “Disability” means a condition entitling the Executive to benefits under the Company’s Long Term Disability Plan, policy or arrangement. 

(b) By the Company. The Company may terminate the Executive’s employment under this Agreement during the Employment Period for Cause or without
Cause. “Cause” means: 
 (i) the continued failure by the Executive to substantially perform his duties as contemplated by this
Agreement (other than any such failure resulting from his incapacity due to physical or mental illness or injury or any such actual or anticipated failure after the issuance by the Executive of a Notice of Termination for Good Reason) over a period
of not less than thirty days after a demand for substantial performance is delivered to the Executive by the Board or by the Chief Executive Officer of the Company, which demand identifies the manner in which it is believed that the Executive has
not substantially performed his duties; 
 (ii) the willful misconduct of the Executive materially and demonstrably injurious to the Company
(including, without limitation, any breach by the Executive of Section 9 of this Agreement); provided that no act or failure to act on the Executive’s part will be considered willful if done, or omitted to be done, by him in good faith and
with reasonable belief that his action or omission was in the best interest of the Company; 
 (iii) the commission by or indictment of the
Executive for a misdemeanor, which, as determined in good faith by the Board, constitutes a crime of moral turpitude and gives rise to material harm to the Company or to any subsidiary or affiliate of the Company; 
 (iv) the commission by or indictment of the Executive for a felony (including, without limitation, any felony constituting a crime of moral turpitude);
or 

 (v) material breach by the Executive of the Executive’s obligations under this Agreement.

 (c) By the Executive. The Executive may terminate employment under this Agreement for Good Reason or without Good Reason. “Good
Reason” means: 
 (i) any reduction in the Executive’s Base Salary, incentive bonus opportunity or long-term incentive
opportunity; or 
 (ii) material failure by the Company to comply with any provision of Sections 2 and 3 of this Agreement, other than an
isolated, insubstantial or inadvertent failure that is not taken in bad faith and is remedied by the Company within 30 days after receipt of written notice thereof from the Executive. 
 Notwithstanding the foregoing, “Good Reason” for purposes of Section 4(c)(i) shall not include a reduction in Base
Salary, incentive bonus or long-term incentive opportunity if such reduction is coincident with a reduction applicable to all members of the senior management team. A termination of employment by the Executive for Good Reason shall be effectuated by
giving the Company written notice (“Notice of Termination for Good Reason”) of the termination, setting forth in reasonable detail the specific conduct that constitutes Good Reason and the specific provision(s) of this Agreement on which
the Executive relies. Such Notice of Termination for Good Reason must be received by the Company no later than the 60th day after the event, or last in a series of events, that gives rise to Good Reason. The Company shall have 20 days to remedy the
conduct set forth in the Notice of Termination for Good Reason. A termination of employment by the Executive for Good Reason shall be effective on the 60th business day following the date when the Notice of Termination for Good Reason is given, unless the conduct set forth in the notice
is remedied by the Company within the 20-day period. A termination of the Executive’s employment by the Executive without Good Reason shall be effected by giving the Company at least 30 days’ advance written notice of the termination.

 (d) Date of Termination. The “Date of Termination” means the date of the Executive’s death, the date of the
Executive’s Disability, the date the termination of the Executive’s employment under this Agreement by the Company for Cause or without Cause or by the Executive for Good Reason or without Good Reason, as the case may be, is effective. The
Employment Period shall end on the Date of Termination. 
 5. Obligations of the Company upon Termination. 
 (a) By the Company Other Than for Cause; or By the Executive for Good Reason. If, during the Employment Period, the Company terminates the
Executive’s employment under this Agreement (other than for Cause) or the Executive terminates employment under this Agreement for Good Reason: 
 (1) the Executive shall be entitled to (i) continued payment for eighteen (18) months after the Date of Termination of the Executive’s current base salary (as in effect on the Date of Termination), and
(ii) a bonus equal to the average of the annual bonuses earned by the Executive over the three complete years (or if less than three years, the average bonus earned during such shorter period) preceding the Date of Termination (that is, not
including the bonus year that includes the Date of Termination) to be paid on the first business day at the conclusion of the eighteen month period after the Date of Termination,; and 
 (2) for the eighteen (18) month period following the Date of Termination, the Executive will receive waiver of the applicable premium
otherwise payable for COBRA continuation coverage for the Executive, his spouse and eligible dependents 

 
(to the extent covered on the Date of Termination) for health, prescription, dental and vision benefits; provided, however, that to the extent COBRA
continuation coverage eligibility expires (unless such expiration is due to eligibility for other group health insurance or Medicare) before the end of such eighteen month period, the Executive will receive payment, on an after-tax basis, of an
amount equal to the premium the Company would have otherwise waived for COBRA coverage. The obligations of the Company to provide benefits under this Section 5(a)(2) shall terminate on the date of occurrence of the first to occur of any of the
following, if any of the following should occur prior to the end of the eighteen (18) month period: (i) the date of commencement of eligibility of the Executive under the group health plan of any other employer or (ii) the date of
commencement of eligibility of the Executive for Medicare benefits. 
 In addition, the Executive shall be entitled to receive executive level outplacement
assistance under any outplacement assistance program then being maintained by the Company in accordance with the terms of any such program. The Executive shall also become vested in any outstanding options, restricted stock or other equity incentive
awards only to the extent provided for under the terms governing such equity incentive award. The Company shall also pay, or cause to be paid, to the Executive, in a lump sum in cash within 30 days after the Date of Termination (or, in the case of
the pro-rated Annual Bonus Amount, at the time such bonus would otherwise be paid), the Executive’s accrued but unpaid cash compensation (the “Accrued Obligations”), which shall include but not be limited to, (W) the
Executive’s base salary through the Date of Termination that has not yet been paid (X) an amount representing a 100% target bonus for the Executive’s salary grade for the year of termination, multiplied by a fraction, the numerator of
which is the number of days in the current fiscal year through the Date of Termination, and the denominator of which is 365 (the “Annual Bonus Amount”), (Y) any accrued but unpaid vacation or PTO pay, and (Z) similar unpaid items
that have accrued and as to which the Executive has become entitled as of the Date of Termination, including declared but unpaid bonuses and unreimbursed employee business expenses; provided, however, that the Company’s obligation to make any
payments, or cause any payments to be made, under this paragraph (a) to the extent any such payment shall not have accrued as of the day before the Date of Termination shall also be conditioned upon the Executive’s execution, and
non-revocation, of a written release, substantially in the form attached hereto as Exhibit 1, of any and all claims against the Company and all related parties with respect to all matters arising out of the Executive’s employment under this
Agreement or the termination thereof (other than any entitlements under the terms of this Agreement to indemnification or under any other plans or programs of the Company in which the Executive participated and under which the Executive has accrued
and is due a benefit). 
 If any payment, compensation or other benefit provided to the Executive in connection with his employment termination is
determined, in whole or in part, to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code and the Executive is a specified employee as defined in Section 409A(a)(2)(B)(i) and Income Tax
Regulations under Section 409A, no part of such payments shall be paid before the day that is six (6) months plus one (1) day after the Date of Termination (the “New Payment Date”). The aggregate of any payments that
otherwise would have been paid to the Executive during the period between the termination date and the New Payment Date shall be paid to the Executive, without interest, in a lump sum on such New Payment Date. Thereafter, any payments that remain
outstanding as of the day immediately following the New Payment Date shall be paid without delay over the time period originally scheduled, in accordance with the terms of this Agreement. 
 (b) Death or Disability. If the Executive’s employment is terminated by reason of the Executive’s death or Disability during the Employment
Period, the Company shall pay the Accrued Obligations to the Executive or the Executive’s estate or legal representative, as applicable, in a lump sum in cash within 30 days after the Date of Termination. If the Executive’s employment is

 
terminated by reason of the Executive’s death, the Executive shall also become vested in any outstanding options, restricted stock or other equity
incentive awards. If the Executive’s employment is terminated by reason of the Executive’s death or Disability, the Company shall have no further obligations under this Agreement or otherwise to or with respect to the Executive other than
for any entitlements under the terms of any other plans or programs of the Company in which the Executive participated and under which the Executive has become entitled to a benefit. 
 (c) By the Company for Cause; By the Executive Other than for Good Reason. If the Executive’s employment is terminated by the Company for Cause
during the Employment Period, or the Executive voluntarily terminates employment during the Employment Period, other than for Good Reason, the Company shall pay the Executive, or shall cause the Executive to be paid, the Executive’s base salary
through the Date of Termination that has not been paid and the amount of any declared but unpaid bonuses, accrued but unpaid vacation or PTO pay, and unreimbursed employee business expenses, and the Company shall have no further obligations under
this Agreement or otherwise to or with respect to the Executive other than for any entitlements under the terms of any other plans or programs of the Company in which the Executive participated and under which the Executive has become entitled to a
benefit. 
 Termination Pursuant to a Change of Control. If there is a Change of Control, as defined in Section 5(d)(i) below, during
the Term, the provisions of this Section 5(d) shall apply and shall continue to apply throughout the remainder of Employment Period. If, within one (1) year following a Change of Control, the Executive’s employment is terminated by
the Company or the Executive following the occurrence of any of the events listed in Section 5(d)(ii) below or if the Executive’s employment is terminated without cause (in accordance with Section 5(a) above), the Company shall pay to
the Executive (or the Executive’s estate, if applicable) the payments described under Section 5(a) and the Executive shall become vested in any outstanding options, restricted stock, or other equity incentive award; provided that the
Company’s obligation to make any payment, or to permit any vesting of outstanding options, restricted stock, or other equity incentive award as described above, shall be conditioned upon the Executive’s execution, and non-revocation, of a
written release, substantially in the form attached hereto as Exhibit 1. 
 (i) Change of Control shall mean the occurrence of
one or more of the following events: 
 (A) any “person” (as such term is used in Sections 13(d) and 14(d)(2) of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) becomes a “beneficial owner” (as such term is defined in Rule 13d-3 promulgated under the Exchange Act) (other than the Company, any trustee or other fiduciary
holding securities under an employee benefit plan of the Company, or any corporation owned, directly or indirectly, by the stockholders of the Company, in substantially the same proportions as their ownership of stock of the Company), directly or
indirectly, of securities of the Company, representing forty percent (40%) or more of the combined voting power of the Company’s then outstanding securities; or 
 (B) persons who, as of the Effective Date, constituted the Company’s Board of Directors (the “Incumbent Board”) cease for
any reason including, without limitation, as a result of a tender offer, proxy contest, merger or similar transaction, to constitute at least a majority of the Board of Directors, provided that any person becoming a director of the Company
subsequent to the Effective Date whose election was approved by at least a majority of the directors then comprising the Incumbent Board shall, for purposes of this Section 5(d), be considered a member of the Incumbent Board; or 

 (C) the stockholders of the Company approve a merger or consolidation of the Company
with any other corporation or other entity, other than (1) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the surviving entity) more than forty percent (40%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or
consolidation or (2) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no “person” (as hereinabove defined) acquires more than forty percent (40%) of the combined
voting power of the Company’s then outstanding securities; or 
 (D) the stockholders of the Company approve a plan of
complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets. 
 (ii) The events referred to in Section 5(d) above shall be as follows: 
 (A) a
reduction of the Executive’s salary other than a reduction that (1) is based on the Company’s financial performance or (2) is similar to the reduction made to the salaries provided to all or most other senior executives of the
Company; or 
 (B) a significant change in the Executive’s responsibilities and/or duties which constitutes, when
compared to the Executive’s responsibilities and/or duties before the Change of Control, a demotion; or 
 (C) a
material loss of title or office; or 
 (D) the relocation of the offices at which the Executive is principally employed as
of the Change of Control to a location more than fifty (50) miles from such offices, which relocation is not approved by the Executive. 
 The Executive shall provide the Company with reasonable notice and an opportunity to cure any of the events listed in Section 5(d)(ii) and shall not be entitled to compensation pursuant to this Section 5(d) unless the Company
fails to cure within a reasonable period; and 
 (iii) It is the intention of the Executive and of the Company that no
payments by the Company to or for the benefit of the Executive under this Agreement or any other agreement or plan, if any, pursuant to which the Executive is entitled to receive payments or benefits shall be nondeductible for federal income tax
purposes to the Company by reason of the operation of Section 280G of the Code relating to parachute payments or any like statutory or regulatory provision. Accordingly, and notwithstanding any other provision of this Agreement or any such
agreement or plan, if by reason of the operation of said Section 280G or any like statutory or regulatory provision, any such payments exceed the amount which can be deducted by the Company, such payments shall be reduced to the maximum amount
which can be deducted by the 

 
Company. To the extent that payments exceeding such maximum deductible amount have been made to or for the benefit of the Executive, such excess payments
shall be refunded to the Company with interest thereon at the applicable Federal rate determined under Section 1274(d) of the Code, compounded annually, or at such other rate as may be required in order that no such payments shall be
nondeductible to the Company by reason of the operation of said Section 280G or any like statutory or regulatory provision. To the extent that there is more than one method of reducing the payments to bring them within the limitations of said
Section 280G or any like statutory or regulatory provision, the Executive shall determine which method shall be followed, provided that if the Executive fails to make such determination within forty-five (45) days after the Company has
given notice of the need for such reduction, the Company may determine the method of such reduction in its sole discretion. 
 6.
Non-exclusivity of Rights. Nothing in this Agreement shall prevent or limit the Executive’s continuing or future participation in any plan, program, policy or practice provided by the Company for which the Executive may qualify. Vested benefits
and other amounts that the Executive is otherwise entitled to receive on or after the Date of Termination under any plan, policy, practice or program of, or any contract or agreement with, the Company shall be payable in accordance with such plan,
policy, practice, program, contract or agreement, as the case may be, except as explicitly modified by this Agreement. 
 7. No Mitigation.
In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced,
regardless of whether the Executive obtains other employment. 
 8. Confidential Information; Non-solicitation; Non-competition. 

(a) The Executive agrees and acknowledges that by reason of his employment by and service to the Company, he will have access to, become exposed to
and/or become knowledgeable about confidential information of the Company (the “Confidential Information”) from time to time during the Employment Period, including, without limitation, proposals, plans, inventions, practices, systems,
programs, processes, methods, techniques, research, records, supplier sources, customer lists and other forms of business information that are not known to the Company’s competitors, are not recognized as being encompassed within standard
business or management practices and/or are kept secret and confidential by the Company. Executive agrees that at no time during or after the Employment Period will he disclose or use the Confidential Information except as may be required in the
prudent course of business for the benefit of the Company. The Executive also agrees to be subject to the Company’s Code of Ethics and Business Conduct as in effect from time to time during the Employment Period. 
 (b) The Executive acknowledges that the Company is generally engaged in business throughout the United States. During the Executive’s employment by
the Company and for eighteen months after the Date of Termination or the expiration of the final Employment Period, the Executive agrees that he will not, unless acting with the prior written consent of the Company, directly or indirectly, own,
manage, control, or participate in the ownership, management or control of, or be employed or engaged by, or otherwise affiliated or associated with, as an officer, director, employee, consultant, independent contractor or otherwise, any other
corporation, partnership, proprietorship, firm, association or other business entity, or otherwise engage in any business, which is engaged in hospital and long term care institutional pharmacy services as of the Date of Termination or expiration of
the final 

 
Employment Period, as applicable, is engaged in by the Company, has been reviewed with the Board for development to be owned or managed by the Company,
and/or has been divested by the Company but as to which the Company has an obligation to refrain from involvement, but only for so long as such restriction applies to the Company; provided, however, that the ownership of not more than 5% of the
equity of a publicly traded entity shall not be deemed to be a violation of this paragraph. During such eighteen month period, Executive also agrees to make himself reasonably available to the Company for consulting at a per diem rate that reflects
his annual salary as in an effect prior to his termination of employment (plus reimbursement of Executive’s reasonable expenses). 
 (c)
The Executive also agrees that he will not, directly or indirectly, during the period described in paragraph (b) of this Section 8 induce any person who is an employee, officer, director, or agent of the Company, to terminate such
relationship, or employ, assist in employing or otherwise be associated in business with any present or former employee or officer of the Company, including without limitation those who commence such positions with the Company after the Date of
Termination. 
 (d) The Executive also agrees that he will not, directly or indirectly, during the period described in paragraph (b) of
this Section 8, (i) solicit or otherwise accept business from any client or customer of the Company or any prospective client or customer of the Company (ii) cause a client or customer, or any prospective client or customer of the
Company, to terminate or otherwise modify adversely its business relationship with the Company. 
 (e) The Executive acknowledges and agrees
that the restrictions contained in this Section 8 are reasonable and necessary to protect and preserve the legitimate interests, properties, goodwill and business of the Company, that the Company would not have entered into this Agreement in
the absence of such restrictions and that irreparable injury will be suffered by the Company should the Executive breach the provisions of this Section. The Executive represents and acknowledges that (i) the Executive has been advised by the
Company to consult the Executive’s own legal counsel in respect of this Agreement, (ii) the Executive has consulted with and been advised by his own counsel in respect of this Agreement, and (iii) the Executive has had full
opportunity, prior to execution of this Agreement, to review thoroughly this Agreement with the Executive’s counsel. 
 (f) The
Executive further acknowledges and agrees that a breach of the restrictions in this Section 8 will not be adequately compensated by monetary damages. The Executive agrees that actual damage may be difficult to ascertain and that, in the event
of any such breach, the Company shall be entitled to injunctive relief in addition to such other legal or equitable remedies as may be available to the Company. In the event that the provisions of this Section 9 should ever be adjudicated to
exceed the limitations permitted by applicable law in any jurisdiction, it is the intention of the parties that the provision shall be amended such that those provisions are made consistent with the maximum limitations permitted by applicable law,
that such amendment shall apply only within the jurisdiction of the court that made such adjudication and that those provisions otherwise be enforced to the maximum extent permitted by law. 
 (g) To the extent that any court action is permitted consistent with or to enforce Section 9 of this Agreement, the Executive agrees that suit may
be brought, and that he consents to personal jurisdiction, in the United States District Court for the Eastern District of Kentucky, or if such court does not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in
Fayette County, Kentucky; consents to the non-exclusive jurisdiction of any such court in any such suit, action or proceeding; and waives any objection which he may have to the laying of venue of any such suit, action or proceeding in any such
court. The Executive also irrevocably and unconditionally consents to the service of any process, pleadings, notices or other papers. 

 (h) For purposes of this Section 8, the term “Company” shall be deemed to include
subsidiaries and affiliates of the Company. 
 (i) The Executive agrees that during his employment he shall not use or disclose to the
Company any confidential or proprietary information obtained in the course of employment with a prior employer. 
 9. Arbitration of
Disputes. Any controversy or claim arising out of or relating to this Agreement or the breach thereof or otherwise arising out of the Executive’s employment or the termination of that employment (including, without limitation, any claims of
unlawful employment discrimination whether based on age or otherwise) shall, to the fullest extent permitted by law, be settled by arbitration in any forum and form agreed upon by the parties or, in the absence of such an agreement, under the
auspices of the American Arbitration Association (“AAA”) in Lexington, Kentucky in accordance with the Employment Dispute Resolution Rules of the AAA, including, but not limited to, the rules and procedures applicable to the selection of
arbitrators. In the event that any person or entity other than the Executive or the Company may be a party with regard to any such controversy or claim, such controversy or claim shall be submitted to arbitration subject to such other person or
entity’s agreement. Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. This Section 9 shall be specifically enforceable. Notwithstanding the foregoing, this Section 9 shall not
preclude either party from pursuing a court action for the sole purpose of obtaining a temporary restraining order or a preliminary injunction in circumstances in which such relief is appropriate; provided that any other relief shall be pursued
through an arbitration proceeding pursuant to this Section 9. 
 10. Successors. This Agreement is personal to the Executive and,
without the prior written consent of the Company, shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive’s legal
representatives. This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business and/or assets of the Company expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would have been required to perform it if no such succession had
taken place. As used in this Agreement, “Company” shall mean both the Company as defined above and any such successor that assumes and agrees to perform this Agreement, by operation of law or otherwise. 
 11. Miscellaneous. 
 (a) This
Agreement shall be governed by, and construed in accordance with, the laws of the State of Kentucky, without reference to principles of conflict of laws. The captions of this Agreement are not part of the provisions hereof and shall have no force or
effect. This Agreement may not be amended or modified except by a written agreement executed by the parties hereto or their respective successors and legal representatives. 
 (b) If a claim or action at law or in equity is commenced to enforce or interpret the terms of this Agreement, including any claim or
action pursuant to Section 9,8, and such claim or action is determined by the presiding fact-finder to be unreasonable, the prevailing party shall be entitled to recover, in addition to any other relief, all attorney’s fees incurred by
such prevailing party 
 (c) All notices and other communications under this Agreement shall be in writing and shall be given
by hand to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
 If to the
Executive, to the address on file with the Company. 
 If to the Company: 
 PharMerica Corporation 
 1901 Campus Place,
Louisville, KY 40299 

 or to such other address as either party furnishes to the other in writing in accordance with this
paragraph (c) of Section 11. Notices and communications shall be effective when actually received by the addressee. 
 (d) The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement. If any provision of this Agreement shall be held invalid or unenforceable in
part, the remaining portion of such provision, together with all other provisions of this Agreement, shall remain valid and enforceable and continue in full force and effect to the fullest extent consistent with law. 
 (e) Notwithstanding any other provision of this Agreement, the Company may withhold from amounts payable under this Agreement all federal,
state, local, and foreign taxes that are required to be withheld by applicable laws or regulations. 
 (f) The
Executive’s or the Company’s failure to insist upon strict compliance with any provision of, or to assert any right under, this Agreement (including, without limitation, the right of the Executive to terminate employment for Good Reason
pursuant to paragraph (c) of Section 5 of this Agreement) shall not be deemed to be a waiver of such provision or right or of any other provision of or right under this Agreement. 
 (g) Anything to the contrary herein notwithstanding, all benefits or payments provided by the Company to the Executive that would be
deemed to constitute “nonqualified deferred compensation” within the meaning of Section 409A are intended to comply with Section 409A of the Code. If, however, any such benefit or payment is deemed to not comply with
Section 409A of the Code, the Company and the Executive agree to renegotiate in good faith any such benefit or payment (including, without limitation, as to the timing of any severance payments payable hereof) so that either
(i) Section 409A of the Code will not apply or (ii) compliance with Section 409A will be achieved. 
 (h)
This Agreement may be executed in several counterparts, each of which shall be deemed an original, and said counterparts shall constitute but one and the same instrument. 
 12. The respective rights and obligations of the parties hereunder shall survive any termination of the Executive’s employment to the extent necessary to the intended preservation of such rights and obligations,
including, but not by way of limitation, those rights and obligations set forth in Sections 3, 5, 6, 8, 9 and 12. 
 {SIGNATURE ON NEXT PAGE}

 IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and, pursuant to the
authorization of the Committee, the Company has caused this Agreement to be executed in its name on its behalf, all as of the day and year first above written. 
  

			
	PHARMERICA CORPORATION
		
	By:	 	 /s/ Anthony A. Hernandez

	Name:	 	 Anthony A. Hernandez

	Title:	 	 Senior Vice President of Human Resources

	
	EXECUTIVE
	
	 /s/ William E. Monast

	William E. Monast

 EXHIBIT 1 
 SEPARATION OF EMPLOYMENT AGREEMENT 
 AND GENERAL RELEASE 
 THIS SEPARATION OF EMPLOYMENT AGREEMENT AND GENERAL RELEASE (the “Agreement”) is made as of this      day of
            ,     , by and between PharMerica Corporation (the “Company”) and
                     (the “Executive”). 
 WHEREAS, Executive formerly was employed as             ; 
 WHEREAS, Executive and Company entered into an Employment Agreement, dated                  ,     , (the
“Employment Agreement”) which provides for certain severance benefits in the event that Executive’s employment is terminated on account of a reason set forth in the Employment Agreement; 
 WHEREAS, Executive and the Company mutually desire to terminate Executive’s employment on an amicable basis, such termination to be effective
                 ,      (the “Date of Resignation”); and 
 WHEREAS, in connection with the termination of Executive’s employment, the parties have agreed to a separation package and the resolution of any and all disputes between them. 
 NOW, THEREFORE, IT IS HEREBY AGREED by and between Executive and the Company as follows: 
 1. (a) Executive, for and in consideration of the commitments of the Company as set forth in Paragraph 5 of this Agreement, and intending to be legally
bound, does hereby REMISE, RELEASE AND FOREVER DISCHARGE the Company, its affiliates, subsidiaries and parents, and its officers, directors, employees, and agents, and its and their respective successors and assigns, heirs, executors, and
administrators (each, a “Releasee” and collectively, “Releasees”) from all causes of action, suits, debts, claims and demands whatsoever in law or in equity, which Executive ever had, now has, or hereafter may have, whether known
or unknown, or which Executive’s heirs, executors, or administrators may have, by reason of any matter, cause or thing whatsoever, from the beginning of Executive’s employment to the date of this Agreement, and particularly, but without
limitation of the foregoing general terms, any claims arising from or relating in any way to Executive’s employment relationship with the Company and/or its predecessors, subsidiaries or affiliates, the terms and conditions of that employment
relationship, and the termination of that employment relationship, including, but not limited to, any claims arising under the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act (“OWBPA”), Title VII of The Civil
Rights Act of 1964, the Americans with Disabilities Act, the Family and Medical Leave Act of 1993, the Employee Retirement Income Security Act of 1974, the Kentucky Civil Rights Act, and any other claims under any federal, state or local common law,
statutory, or regulatory provision, now or hereafter recognized, and any claims for attorneys’ fees and costs. This Agreement is effective without regard to the legal nature of the claims raised and without regard to whether any such claims are
based upon tort, equity, implied or express contract or discrimination of any sort. 
 (b) To the fullest extent permitted by law, and
subject to the provisions of Paragraph 10 below, Executive represents and affirms that (i) Executive has not filed or caused to be filed on Executive’s behalf any claim for relief against the Company or any Releasee and, to the best of
Executive’s knowledge and belief, no outstanding claims for relief have been filed or asserted against the 

 
Company or any Releasee on Executive’s behalf; (ii) Executive has not reported any improper, unethical or illegal conduct or activities to any
supervisor, manager, department head, human resources representative, agent or other representative of the Company, to any member of the Company’s legal or compliance departments, or to the ethics hotline, and has no knowledge of any such
improper, unethical or illegal conduct or activities; and (iii) Executive will not file, commence, prosecute or participate in any judicial or arbitral action or proceeding against the Company or any Releasee based upon or arising out of any
act, omission, transaction, occurrence, contract, claim or event existing or occurring on or before the date of this Agreement. 
 (c)
Nothing in the Agreement will be deemed to release the Company from (i) claims solely to enforce this Agreement, (ii) claims for indemnification under the Company’s By-Laws, or (iii) claims for payment or reimbursement pursuant
to any employee benefit plan, policy or arrangement of the Company. 
 2. In consideration of the Company’s agreements as set forth in
Paragraph 5 herein, Executive agrees to be bound by the terms of Section 9 of the Employment Agreement. 
 3. Executive agrees and
recognizes that Executive has permanently and irrevocably severed Executive’s employment relationship with the Company, that Executive shall not seek employment with the Company or any affiliated entity at any time in the future, and that the
Company has no obligation to employ Executive in the future. 
 4. Executive further agrees that Executive will not disparage or subvert the
Company, or make any statement reflecting negatively on the Company, its affiliated corporations or entities, or any of their officers, directors, employees, agents or representatives, including, but not limited to, any matters relating to the
operation or management of the Company, Executive’s employment and the termination of Executive’s employment, irrespective of the truthfulness or falsity of such statement. The Company agrees that none of its officers, directors,
employees, agents or representatives will disparage or subvert the Executive, or make any statement reflecting negatively on the Executive, including, but not limited to, any matters relating to the Executive’s performance or the termination of
Executive’s employment, irrespective of the truthfulness or falsity of such statement. 
 5. In consideration for Executive’s
agreement as set forth herein, the Company agrees that the Company shall provide the following: 
 (a) The severance benefits
described in section 5(a) of the Employment Agreement; and 
 (b) The Company will maintain, for no less than 6 years
following the Date of Resignation, directors’ and officers’ liability insurance covering the Executive’s potential liability in connection with his employment by the Company in amounts and on terms that are commensurate with the
coverage provided to its active officers and directors of the Company. 
 6. Executive understands and agrees that the payments, benefits and
agreements provided in this Agreement are being provided to Executive in consideration for Executive’s acceptance and execution of, and in reliance upon Executive’s representations in, this Agreement. Executive acknowledges that if
Executive had not executed this Agreement containing a release of all claims against the Company, Executive would only have been entitled to the payments provided in the Company’s standard severance pay plan for employees. 

 7. Executive acknowledges and agrees that the Company previously has satisfied any and all obligations
owed to Executive under any employment agreement or offer letter Executive has with the Company and, further, that this Agreement supersedes any employment agreement or offer letter Executive has with the Company, and any and all prior agreements or
understandings, whether written or oral, between the parties shall remain in full force and effect to the extent not inconsistent with this Agreement, and further, that, except as set forth expressly herein, no promises or representations have been
made to Executive in connection with the termination of Executive’s employment agreement or offer letter with the Company, or the terms of this Agreement. 
 8. Executive agrees not to disclose the terms of this Agreement to anyone, except Executive’s spouse, attorney and, as necessary, tax/financial advisor. Likewise, the Company agrees that the terms of this
Agreement will not be disclosed except as may be necessary to obtain approval or authorization to fulfill its obligations hereunder or as required by law. It is expressly understood that any violation of the confidentiality obligation imposed
hereunder constitutes a material breach of this Agreement. 
 9. Executive represents that Executive does not presently have in
Executive’s possession any records and business documents, whether on computer or hard copy, and other materials (including but not limited to computer disks and tapes, computer programs and software, office keys, correspondence, files,
customer lists, technical information, customer information, pricing information, business strategies and plans, sales records and all copies thereof) (collectively, the “Corporate Records”) provided by the Company and/or its predecessors,
subsidiaries or affiliates or obtained as a result of Executive’s prior employment with the Company and/or its predecessors, subsidiaries or affiliates, or created by Executive while employed by or rendering services to the Company and/or its
predecessors, subsidiaries or affiliates. Executive acknowledges that all such Corporate Records are the property of the Company. In addition, Executive shall promptly return in good condition any and all beepers, credit cards, cellular telephone
equipment, business cards and computers. As of the Date of Resignation, the Company will make arrangements to remove, terminate or transfer any and all business communication lines including network access, cellular phone, fax line and other
business numbers. 
 10. Nothing in this Agreement shall prohibit or restrict Executive from: (i) making any disclosure of information
required by law; (ii) providing information to, or testifying or otherwise assisting in any investigation or proceeding brought by, any federal regulatory or law enforcement agency or legislative body, any self-regulatory organization, or the
Company’s General Counsel or Human Resources Director; or (iii) filing, testifying, participating in or otherwise assisting in a proceeding relating to an alleged violation of any federal, state or municipal law relating to fraud, or any
rule or regulation of the Securities and Exchange Commission or any self-regulatory organization. 
 11. The parties agree and acknowledge
that the agreement by the Company described herein, and the settlement and termination of any asserted or unasserted claims against the Releasees, are not and shall not be construed to be an admission of any violation of any federal, state or local
statute or regulation, or of any duty owed by any of the Releasees to Executive. 
 12. Executive agrees and recognizes that should Executive
breach any of the obligations or covenants set forth in this Agreement, the Company will have no further obligation to provide Executive with the consideration set forth herein, and will have the right to seek repayment of all consideration paid up
to the time of any such breach. Further, Executive acknowledges in the event of a breach of this Agreement, Releasees may seek any and all appropriate relief for any such breach, including equitable relief and/or money damages, attorney’s fees
and costs. 

 13. Executive further agrees that the Company shall be entitled to preliminary and permanent injunctive
relief, without the necessity of proving actual damages, as well as to an equitable accounting of all earnings, profits and other benefits arising from any violations of this Agreement, which rights shall be cumulative and in addition to any other
rights or remedies to which the Company may be entitled. 
 14. This Agreement and the obligations of the parties hereunder shall be
construed, interpreted and enforced in accordance with the laws of the State of Kentucky. 
 15. Executive certifies and acknowledges as
follows: 
 (a) That Executive has read the terms of this Agreement, and that Executive understands its terms and effects, including the fact
that Executive has agreed to RELEASE AND FOREVER DISCHARGE the Company and each and everyone of its affiliated entities from any legal action arising out of Executive’s employment relationship with the Company and the termination of that
employment relationship; 
 (b) That Executive has signed this Agreement voluntarily and knowingly in exchange for the consideration
described herein, which Executive acknowledges is adequate and satisfactory to Executive and which Executive acknowledges is in addition to any other benefits to which Executive is otherwise entitled; 
 (c) That Executive has been and is hereby advised in writing to consult with an attorney prior to signing this Agreement; 
 (d) That Executive does not waive rights or claims that may arise after the date this Agreement is executed; 
 (e) That the Company has provided Executive with a period of twenty-one (21) days within which to consider this Agreement, and that Executive has
signed on the date indicated below after concluding that this Agreement is satisfactory to Executive; and 
 (f) Executive acknowledges that
this Agreement may be revoked by Executive within seven (7) days after execution, and it shall not become effective until the expiration of such seven day revocation period. In the event of a timely revocation by Executive, this Agreement will
be deemed null and void and the Company will have no obligations hereunder. 
 [SIGNATURE PAGE FOLLOWS] 

 Intending to be legally bound hereby, Executive and the Company executed the foregoing Separation of
Employment Agreement and General Release this              day of             ,     . 
  

									
	  
	 		 	Witness:	 	  

	William Monast	 		 		 	
				
	PHARMERICA CORPORATION	 		 		 	
					
	By:	 	  
	 		 	Witness:	 	  

					
	Name:	 	  
	 		 		 	
					
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]